Johannes Gutenberg-Universität Mainz
- 6131/39-0
Dutzmann, Christina M.; Spix, Claudia; Popp, Isabell et al.
Cancer in Children With Fanconi Anemia and Ataxia-Telangiectnsia-A Nationwide Register-Based Cohort Study in GermanyJOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 1. 2022 S. 32-+
Srivastava, Raj Kamal; de Azua, Inigo Ruiz; Conrad, Andrea et al.
Cannabinoid CB1 Receptor Deletion from Catecholaminergic Neurons Protects from Diet-Induced ObesityINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 23. H. 20. 2022
Sanchez-de la Torre, Anibal; Aguado, Tania; Huerga-Gomez, Alba et al.
Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in miceCELL DEATH & DISEASE. Bd. 13. H. 7. 2022
Brusselle, G.; Barnes, N.; Buhl, R. et al.
CAPTAIN: Relationship between FEV1 reversibility at screening as a continuous variable and treatment responseALLERGY AND ASTHMA PROCEEDINGS. Bd. 43. H. 6. 2022 S. 561-561
Kroumpouzos, George; Arora, Gulhima; Kassir, Martin et al.
Carboxytherapy in dermatologyCLINICS IN DERMATOLOGY. Bd. 40. H. 3. 2022 S. 305-309
Pleming, William; Barco, Stefano; Voci, Davide et al.
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysisHAMOSTASEOLOGIE. Bd. 42. H. 04. 2022 S. 261-267
Lackner, Karl J.
Cardiac troponins - a paradigm for diagnostic biomarker identification and developmentCLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022
Kuntic, Marin; Djordjevic, Ivana; Oelze, Matthias et al.
CARDIO-PULMONARY CONSEQUENCES OF SYNERGISTIC EXPOSURE TO PARTICULATE MATTER AND NOISE POLLUTIONFREE RADICAL BIOLOGY AND MEDICINE. Bd. 189. 2022 S. 17-17
Baczalska, Justyna; Wojciechowska, Wiktoria; Rojek, Marta et al.
Cardiovascular consequences of aircraft noise exposureFRONTIERS IN PUBLIC HEALTH. Bd. 10. 2022
Zolk, Oliver; von dem Knesebeck, Annika; Graf, Norbert et al.
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort StudyJMIR RESEARCH PROTOCOLS. Bd. 11. H. 2. 2022